1. EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA. (1st June 2021) Authors: Valinciute, Gintvile; Ecker, Jonas; Selt, Florian; Hielscher, Thomas; Schmidt, Christin; Sigaud, Romain; Ridinger, Johannes; Gatzweiler, Charlotte; Picard, Daniel; Oppermann, Sina; Blattner-Johnson, Mirjam; Jones, David T W; Oehme, Ina; Kool, Marcel; Remke, Marc; Pfister, Stefan M; Witt, Olaf; Mi... Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics. (3rd June 2022) Authors: Sigaud, Romain; Rösch, Lisa; Gatzweiler, Charlotte; Benzel, Julia; von Soosten, Laura; Peterziel, Heike; Najafi, Sara; Ayhan, Simay; Gerloff, Xena F; Hofmann, Nina; Büdenbender, Isabel; Foerster, Kathrin I; Burhenne, Jürgen; Longuespée, Rémi; van Tilburg, Cornelis M; Jones, David T W; Pfister, St... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models. Issue 3 (27th July 2022) Authors: Sigaud, Romain; Rösch, Lisa; Gatzweiler, Charlotte; Benzel, Julia; von Soosten, Laura; Peterziel, Heike; Selt, Florian; Najafi, Sara; Ayhan, Simay; Gerloff, Xenia F; Hofmann, Nina; Büdenbender, Isabel; Schmitt, Lukas; Foerster, Kathrin I; Burhenne, Jürgen; Haefeli, Walter E; Korshunov, ... Journal: Neuro-oncology Issue: Volume 25:Issue 3(2023) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗